Sanofi to buy Genzyme for more than $20 billion (Reuters)

Reuters - French drugmaker Sanofi-Aventis SA clinched its long-sought deal for Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group's drugs.

Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20110216/ts_nm/us_genzyme_sanofi

cause of mesothelioma mesothelioma patients mesothelioma doctor